IRIS Accounts Production v25.4.0.155 15329542 Board of Directors 1.1.25 31.12.25 31.12.25 12.8.26 true false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh153295422024-12-31153295422025-12-31153295422025-01-012025-12-31153295422023-12-05153295422023-12-062024-12-31153295422024-12-3115329542ns15:EnglandWales2025-01-012025-12-3115329542ns14:PoundSterling2025-01-012025-12-3115329542ns10:Director12025-01-012025-12-3115329542ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3115329542ns10:SmallEntities2025-01-012025-12-3115329542ns10:Audited2025-01-012025-12-3115329542ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3115329542ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3115329542ns10:FullAccounts2025-01-012025-12-3115329542ns10:Director22025-01-012025-12-3115329542ns10:CompanySecretary12025-01-012025-12-3115329542ns10:RegisteredOffice2025-01-012025-12-3115329542ns5:CurrentFinancialInstruments2025-12-3115329542ns5:CurrentFinancialInstruments2024-12-3115329542ns5:ShareCapital2025-12-3115329542ns5:ShareCapital2024-12-3115329542ns5:FurtherSpecificReserve2ComponentTotalEquity2025-12-3115329542ns5:FurtherSpecificReserve2ComponentTotalEquity2024-12-3115329542ns5:RetainedEarningsAccumulatedLosses2025-12-3115329542ns5:RetainedEarningsAccumulatedLosses2024-12-3115329542ns5:AdditionsToInvestments2025-12-3115329542ns5:CostValuation2025-12-3115329542ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3115329542ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3115329542ns5:AfterOneYearns5:Non-currentFinancialInstruments2025-12-3115329542ns5:AfterOneYearns5:Non-currentFinancialInstruments2024-12-31
REGISTERED NUMBER: 15329542 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

MEDABLE UK LIMITED

MEDABLE UK LIMITED (REGISTERED NUMBER: 15329542)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company information 1

Balance sheet 2

Notes to the financial statements 3


MEDABLE UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







Directors: M H Pak
J D Freeman





Secretary: M H Pak





Registered office: Suite 2, Ground Floor,
Templeback
10 Temple Back
Bristol
United Kingdom
BS1 6FL





Registered number: 15329542 (England and Wales)





Auditors: Zome (Statutory Auditor)
5th Floor
111 Charterhouse Street
London
EC1M 6AW

MEDABLE UK LIMITED (REGISTERED NUMBER: 15329542)

BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £ £
FIXED ASSETS
Investments 4 7 -

CURRENT ASSETS
Debtors 5 1,210,385 290,020
Cash at bank 489,359 1,167,012
1,699,744 1,457,032
CREDITORS
Amounts falling due within one year 6 (563,783 ) (866,562 )
NET CURRENT ASSETS 1,135,961 590,470
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,135,968

590,470


CAPITAL AND RESERVES
Called up share capital 1 1
Other reserves 205,616 124,130
Retained earnings 930,351 466,339
SHAREHOLDERS' FUNDS 1,135,968 590,470
1,135,968 590,470

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 August 2026 and were signed on its behalf by:





M H Pak - Director


MEDABLE UK LIMITED (REGISTERED NUMBER: 15329542)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Medable UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The company's functional and presentational currency is pounds sterling (GBP) and the financial statements have been rounded to the nearest pound (£).

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover represents amounts charged to the company's parent under a sales and marketing agreement, excluding value added tax. Turnover is recognised when chargeable costs are incurred.

Other investment
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into.

Basic financial liabilities
Basic financial liabilities, including creditors, and loans from fellow group companies are initially recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are initially recognised at transaction price.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MEDABLE UK LIMITED (REGISTERED NUMBER: 15329542)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Stock option expense
Judgement and estimation are required in determining the fair value of the shares at the date of award. The fair value is estimated using valuation techniques which take into account the award's term, the risk-free interest rate and the expected volatility of the market price of the parent company's shares. Judgement and estimation are also required to assess the number of options expected to vest.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2024 - 32 ) .

4. FIXED ASSET INVESTMENTS
Other
investments
£
Cost
Additions 7
At 31 December 2025 7
Net book value
At 31 December 2025 7

5. DEBTORS
2025 2024
£ £
Amounts falling due within one year:
Amounts owed by group undertakings 1,174,488 275,347
Other debtors 9,616 -
1,184,104 275,347

Amounts falling due after more than one year:
Other debtors 26,281 14,673

Aggregate amounts 1,210,385 290,020

MEDABLE UK LIMITED (REGISTERED NUMBER: 15329542)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Taxation and social security 420,823 330,645
Other creditors 142,960 535,917
563,783 866,562

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the auditors was unqualified.

Roy Davis (Senior Statutory Auditor)
for and on behalf of Zome (Statutory Auditor)

8. RELATED PARTY DISCLOSURES

During the financial year, amounts recharged to the parent entity under the terms of the sales and marketing agreement amounted to £7,200,536 (2024 - £7,186,728). At the year end, £1,174,488 was owed by the parent to the Company (2024 - £275,347).

9. ULTIMATE CONTROLLING PARTY

The company's immediate and ultimate parent company is Medable Inc., an entity incorporated in the United States of America.

10. SHARE-BASED PAYMENT TRANSACTIONS

The company has taken the exemption provided in FRS 102 Section 1.12D not to disclose details of share-based payment arrangements concerning equity instruments of another group entity.